July 25, 2012

KeraFAST Opens New Headquarters in Boston

From left to right: Kendalle Burlin O'Connell, Director of Strategic Alliances/In-House Counsel, MassBio, Peter Meade, Director, Boston Redevelopment Authority, Robert Bondaryk, Ph.D., President and CEO, KeraFAST, Inc., and Susan Windham-Bannister, Ph.D., President and CEO, Massachusetts Life Sciences Center, celebrate KeraFAST's opening of their new headquarters in Boston's Innovation District.
From left to right: Kendalle Burlin O’Connell, Director of Strategic Alliances/In-House Counsel, MassBio, Peter Meade, Director, Boston Redevelopment Authority, Robert Bondaryk, Ph.D., President and CEO, KeraFAST, Inc., and Susan Windham-Bannister, Ph.D., President and CEO, Massachusetts Life Sciences Center, celebrate KeraFAST’s opening of their new headquarters in Boston’s Innovation District.

On July 25, 2012, KeraFAST, Inc., a Life Science Research Products Company that offers unique bioreagents, rare laboratory research materials and services, opened its new headquarters in Boston with an official ribbon-cutting ceremony attended by state, local and industry officials. The company’s new 3,000 square foot facility is located at 27 Drydock Ave. in Boston’s Innovation District. Mayor Menino’s life sciences program, LifeTech, assisted KeraFAST, Inc in finding the location. The company had previously been headquarted in North Carolina.